Is Cresco Labs (CRLBF) stock a good buy?
According to the issued ratings of 5 analysts in the last year, the consensus rating for Cresco Labs stock is Buy based on the current 5 buy ratings for CRLBF. The average twelve-month price target for Cresco Labs is $26.80 with a high price target of $36.00 and a low price target of $19.00.
What is the price targets for CRLBF?
The high price target for CRLBF is $14.00 and the low price target for CRLBF is $11.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Where can I buy shares of CRLBF?
Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What was the price of Cresco Labs in the last trading day?
No changes to the price of Cresco Labs Inc. stock on the last trading day (Thursday, 20th Jan 2022). During the day the stock fluctuated 0% from a day low at $6.76 to a day high of $6.76.
Is CRLBF stock a buy?
Cresco Labs Inc (OTCQX International:CRLBF) The 17 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 11.71, with a high estimate of 24.19 and a low estimate of 3.68. The median estimate represents a +228.81% increase from the last price of 3.56.
Does Cresco Labs pay a dividend?
Does Cresco issue dividends? No. The Company does not expect to issue dividends.
Is CRLBF an OTC stock?
Stock Quote (U.S.: OTC) | MarketWatch....$ 3.2000.CloseChgChg %$3.1600-0.2294-6.77%Jul 15, 2022
Who owns CRLBF stock?
Top Institutional HoldersHolderSharesValueRothschild Investment Corporation38,300133,919Carter Financial Group, Inc.21,80576,243Bridges Investment Management, Inc.15,44353,997Captrust Financial Advisors2,92610,2317 more rows
Is Cresco Labs publicly traded?
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use.
Is Crlbf a good buy Zacks?
A value under 20 is generally considered good....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return5Strong Sell2.45%S&P50010.91%4 more rows
Is Cresco Labs a good brand?
Cresco Labs brands are an excellent source for cannabis products that are high in THC and are of good quality. They offer various products, and customers can trust they get THC without heavy metals or hazardous chemicals.
Is Cresco Labs an American company?
Cresco Labs (CSE: CL) (OTCQX: CRLBF), based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy.
Who company owns Sunnyside dispensary?
Cresco LabsSunnyside* is the first national retail brand of Cresco Labs, whose mission is to normalize, professionalize and revolutionize cannabis.
How many stores does Cresco Labs have?
National Retail Footprint Our 50 operational dispensaries give us the ability to not only sell our own products but focus on educating and building trust within the surrounding communities.
How many retail stores does Cresco Labs have?
50 operationalHeadquartered in Chicago, the firm employs over 3,500 people and operates in ten states. Cresco has 50 operational retail locations, 28 cultivation, and production facilities, and wholesales to over 1,000 dispensaries.
Should I buy or sell Cresco Labs stock right now?
7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are current...
What is Cresco Labs' stock price forecast for 2022?
7 brokers have issued 1-year price objectives for Cresco Labs' stock. Their forecasts range from $5.00 to $36.00. On average, they predict Cresco L...
How has Cresco Labs' stock performed in 2022?
Cresco Labs' stock was trading at $6.67 on January 1st, 2022. Since then, CRLBF stock has decreased by 48.3% and is now trading at $3.45. View the...
Are investors shorting Cresco Labs?
Cresco Labs saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 867,900 shares, a drop of 35.0% fro...
When is Cresco Labs' next earnings date?
Cresco Labs is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Cresco...
Who are Cresco Labs' key executives?
Cresco Labs' management team includes the following people: Mr. Charles Bachtell , Co-Founder, CEO & Director (Age 42, Pay $537.5k) Mr. Dennis M...
Who are some of Cresco Labs' key competitors?
Some companies that are related to Cresco Labs include Tilray (TLRY) , Canopy Growth (CGC) , USANA Health Sciences (USNA) , Cronos Group (CRON)...
What is Cresco Labs' stock symbol?
Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."
How do I buy shares of Cresco Labs?
Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
About Cresco Labs
Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.
Signals & Forecast
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cresco Labs stock. View analyst ratings for Cresco Labs or view top-rated stocks.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cresco Labs Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Is Cresco Labs Inc. stock A Buy?
Cresco Labs Inc. finds support from accumulated volume at $6.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
About Cresco Labs Inc
Cresco Labs Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Cresco Labs (OTCMKTS:CRLBF) Price Target and Consensus Rating
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Analyst Ratings By Month
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Cresco Labs (OTCMKTS:CRLBF) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
